A commentary on: TDO2‐augmented fibroblasts secrete EVs enriched in immunomodulatory Y‐derived small RNA

A commentary on: TDO2‐augmented fibroblasts secrete EVs enriched in immunomodulatory Y‐derived small RNA

Bibliographic Details
Main Authors:	Clarissa Sastrawidjaya, Phuong H. D. Nguyen
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	Journal of Extracellular Biology
Subjects:	extracellular vesicles tryptophan 2,3‐dioxygenase fibroblasts myocardial infarction regenerative medicine
Online Access:	https://doi.org/10.1002/jex2.99

Similar Items

TDO2‐augmented fibroblasts secrete EVs enriched in immunomodulatory Y‐derived small RNA
by: Alessandra Ciullo, et al.
Published: (2023-02-01)

On the nonredundant roles of TDO2 and IDO1
by: Paolo ePuccetti
Published: (2014-10-01)

Comprehensive behavioral analysis of tryptophan 2,3‐dioxygenase (Tdo2) knockout mice
by: Satoko Hattori, et al.
Published: (2018-06-01)

High levels of TDO2 in relation to pro-inflammatory cytokines in synovium and synovial fluid of patients with osteoarthritis
by: Genxiang Rong, et al.
Published: (2022-06-01)

Tryptophan-degrading enzymes in tumoral immune resistance
by: Nicolas van Baren, et al.
Published: (2016-11-01)

Responses of growth performance and tryptophan metabolism to oxidative stress induced by diquat in weaned pigs
by: M. Lv, et al.
Published: (2012-01-01)

Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2
by: Sofian M Tijono, et al.
Published: (2022-08-01)

TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
by: Lei Li, et al.
Published: (2021-01-01)

Systemic tryptophan homeostasis
by: Simon Klaessens, et al.
Published: (2022-09-01)

Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target
by: Freek J. H. Sorgdrager, et al.
Published: (2019-10-01)

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
by: Yu Yao, et al.
Published: (2021-02-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01)

Low Levels of Serum Tryptophan Underlie Skeletal Muscle Atrophy
by: Soranobu Ninomiya, et al.
Published: (2020-04-01)

Serum neopterin concentrations and tryptophan degradation pattern in patients with late stage larynx carcinoma
by: Engin Ayse Basak, et al.
Published: (2017-08-01)

Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas
by: Pilvi Maliniemi, et al.
Published: (2017-03-01)

AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases
by: Qingqing Dai, et al.
Published: (2021-07-01)

Pharmacological Targets of Kaempferol Within Inflammatory Pathways—A Hint Towards the Central Role of Tryptophan Metabolism
by: Stefanie Hofer, et al.
Published: (2020-02-01)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
by: Florent Peyraud, et al.
Published: (2022-01-01)

The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
by: Dietmar Fuchs, et al.
Published: (2010-08-01)

The Kynurenine Pathway As a Novel Link between Allergy and the Gut Microbiome
by: Aaron P. Van der Leek, et al.
Published: (2017-11-01)

Serial Analysis of Tryptophan Degradation and Neopterin Formation in an otherwise Healthy Individual before and during an Infectious Episode
by: Huber Leonhard, et al.
Published: (2006-02-01)

The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
by: Knut A. Hestad, et al.
Published: (2017-10-01)

Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients
by: Tingming Cao, et al.
Published: (2022-01-01)

Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells
by: Marta Cecchi, et al.
Published: (2021-03-01)

Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
by: Concetta Elisa Onesti, et al.
Published: (2019-07-01)

Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
by: Karl Savonije, et al.
Published: (2023-05-01)

Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis
by: Yanyan Hu, et al.
Published: (2022-10-01)

An exploratory study of neopterin and kynurenine pathway in pterygium
by: Kilicarslan Bilge, et al.
Published: (2019-08-01)

IDO Expression in Cancer: Different Compartment, Different Functionality?
by: Annabel Meireson, et al.
Published: (2020-09-01)

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
by: Heinz Zoller, et al.
Published: (2015-06-01)

Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
by: Shivani Krishnamurthy, et al.
Published: (2021-10-01)

Kynurenines as a Novel Target for the Treatment of Malignancies
by: Adrian Mor, et al.
Published: (2021-06-01)

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents
by: Hui Wen, et al.
Published: (2019-06-01)

The role of tryptophan in Chlamydia trachomatis persistence
by: Li Wang, et al.
Published: (2022-08-01)

Late-stage systemic immune effectors in Plasmodium berghei ANKA infection: biopterin and oxidative stress
by: Dogruman-Al Funda, et al.
Published: (2015-09-01)

Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer
by: Dyah L. Dewi, et al.
Published: (2017-02-01)

Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
by: Delia Hoffmann, et al.
Published: (2020-12-01)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
by: Peng X, et al.
Published: (2022-08-01)

Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer
by: Madhur Wyatt, et al.
Published: (2021-04-01)

Dexamethasone Promotes a Stem-Like Phenotype in Human Melanoma Cells via Tryptophan 2,3 Dioxygenase
by: Marta Cecchi, et al.
Published: (2022-06-01)